シンガポール - 英語 - HSA (Health Sciences Authority)

vantive pte. ltd. - (large compartment) disodium phosphate dihydrate; (large compartment) potassium chloride; (large compartment) sodium chloride; (large compartment) sodium hydrogen carbonate; (small compartment) calcium chloride dihydrate; (small compartment) magnesium chloride hexahydrate - solution, sterile - (large compartment) disodium phosphate dihydrate 0.225 g/l; (large compartment) potassium chloride 0.314 g/l; (large compartment) sodium chloride 6.435 g/l; (large compartment) sodium hydrogen carbonate 2.918 g/l; (small compartment) calcium chloride dihydrate 3.675g/l; (small compartment) magnesium chloride hexahydrate 2.440 g/l

シンガポール - 英語 - HSA (Health Sciences Authority)

vantive pte. ltd. - sodium chloride; sodium citrate - solution, sterile - sodium chloride 5.03 g/l; sodium citrate 5.29 g/l

イスラエル - 英語 - Ministry of Health

teva israel ltd - glucose as monohydrate; sodium chloride - solution for infusion - glucose as monohydrate 5 %w/v; sodium chloride 0.45 %w/v - electrolytes with carbohydrates - sodium chloride 0.45 % and glucose 5 % soution for infusion baxter is indicated to provide electrolytes and calories and as a source of water for hydration

イスラエル - 英語 - Ministry of Health

teva israel ltd - glucose as monohydrate; sodium chloride - solution for infusion - glucose as monohydrate 5 %w/v; sodium chloride 0.9 %w/v - electrolytes with carbohydrates - sodium chloride 0.9 % and glucose 5 % solution for infusion baxter is indicated as a source of water, electrolytes and/or calories.

イスラエル - 英語 - Ministry of Health

baxter healthcare distribution ltd., israel - glucose as monohydrate; sodium chloride - solution for infusion - sodium chloride 0.18 %w/v; glucose as monohydrate 4.00 %w/v - electrolytes with carbohydrates - sodium chloride 0.18 % and glucose 4% solution is used in the following indications:dehydration treatment due to a moderated loss of sodium and chloride (vomiting, diarrhoea, renal disorders, overuse ofdiuretics) in cases where a source of energy is required (particularly starvation).paediatric population:this product should only be used in paediatric specialist settings (such as renal, hepatic and cardiac units, highdependency units and intensive care units) for intravenous fluid therapy requiring the use of 0.18% sodium chloride and4% glucose to maintain fluid and electrolyte balance.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - metformin hydrochloride -

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - chlorhexidine acetate - irrigation solution - 0.05 percent weight/volume - antiinfectives; chlorhexidine

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - dexmedetomidine hydrochloride - concentrate for solution for infusion - 100 microgram(s)/millilitre - dexmedetomidine

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - sodium chloride; glucose monohydrate ph. eur.; sodium acetate, trihydrate; potassium chloride ph. eur.; magnesium chloride hexahydrate ph. eur. - solution for infusion - 55.00 gram(s)/litre - electrolytes with carbohydrates

マルタ - 英語 - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - glucose anhydrous, sodium chloride, sodium acetate, trihydrate, potassium chloride, magnesium chloride, hexahydrate - solution for infusion - sodium acetate trihydrate 3.13 g glucose anhydrous 50 g sodium chloride 1 g potassium chloride 1.5 g magnesium chloride hexahydrate 0.30 g - blood substitutes and perfusion solutions